ACADIA PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$20.59
-0.82%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+3.5%
3 months
-19.6%
6 months
-6.2%
1 year
-9.4%
Year to date
-22.9%
52-week range
$18.62 – $30.57
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$3.55B
P/E
9.3
P/B
2.7
P/S
3.1
Revenue
$1.14B
Net income
$380.48M
Diluted EPS
2.23
Gross margin
91.10%
Net margin
33.40%
Return on equity
32.40%
Total debt
$59.55M
Cash
$392.83M
Free cash flow
$145.63M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $307.96M | $31.5M | 90.80% | 10.20% | $95.69M |
| Mar 31, 2026 | $268.06M | $3.64M | 90.80% | 1.40% | $28.77M |
| Dec 31, 2025 | $283.99M | $273.57M | 90.80% | 96.30% | -$52.74M |
| Sep 30, 2025 | $278.63M | $71.78M | 92.20% | 25.80% | $73.9M |
| Jun 30, 2025 | $264.57M | $26.67M | 92.20% | 10.10% | $63.66M |
| Mar 31, 2025 | $244.32M | $18.99M | 91.70% | 7.80% | $20.32M |
| Dec 31, 2024 | $259.6M | $143.74M | 91.60% | 55.40% | $39.93M |
| Sep 30, 2024 | $250.4M | $32.77M | 92.50% | 13.10% | $63.18M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ACAD news
All market newsNo ticker-linked stories are in the current archive.